Cargando…
The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who do not receive definitive surgery of the tumor
BACKGROUND AND PURPOSE: Immunotherapy has shown great efficacy in many cancers, but its role in pancreatic ductal adenocarcinoma (PDAC) remains unclear. The objective of this study was to investigate the impact of immunotherapy on the overall survival of PDAC patients who did not receive definitive...
Autores principales: | Amin, Saber, Baine, Michael, Meza, Jane, Alam, Morshed, Lin, Chi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317682/ https://www.ncbi.nlm.nih.gov/pubmed/32613090 http://dx.doi.org/10.1016/j.ctro.2020.06.003 |
Ejemplares similares
-
The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who received definitive surgery of the pancreatic tumor: a retrospective analysis of the National Cancer Database
por: Amin, Saber, et al.
Publicado: (2020) -
The Association of the Sequence of Immunotherapy With the Survival of Unresectable Pancreatic Adenocarcinoma Patients: A Retrospective Analysis of the National Cancer Database
por: Amin, Saber, et al.
Publicado: (2020) -
Association of Immunotherapy With Survival Among Patients With Brain Metastases Whose Cancer Was Managed With Definitive Surgery of the Primary Tumor
por: Amin, Saber, et al.
Publicado: (2020) -
The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective analysis
por: Amin, Saber, et al.
Publicado: (2020) -
The impact of treatment facility type on the survival of brain metastases patients regardless of the primary cancer type
por: Amin, Saber, et al.
Publicado: (2021)